Where is blood produced

Content on WhatAnswers is provided "as is" for informational purposes. While we strive for accuracy, we make no guarantees. Content is AI-assisted and should not be used as professional advice.

Last updated: April 8, 2026

Quick Answer: Blood is primarily produced in the bone marrow through a process called hematopoiesis. In adults, this occurs mainly in flat bones like the pelvis, sternum, and vertebrae, producing approximately 200 billion red blood cells daily. In fetuses, blood production also occurs in the liver and spleen before shifting to bone marrow around birth.

Key Facts

Adult bone marrow produces about 200 billion red blood cells daily
Hematopoiesis begins in the yolk sac during embryonic development at 3 weeks
Bone marrow contains approximately 2.6 kg of tissue in adults
Red blood cells have a lifespan of about 120 days
The spleen can resume blood production in adults during severe anemia

Overview

Blood production, scientifically known as hematopoiesis, is the biological process through which the body generates blood cells. This continuous process is essential for maintaining oxygen transport, immune function, and clotting capabilities throughout life. The understanding of blood production has evolved significantly since ancient times when blood was considered one of the four bodily humors. Modern hematology emerged in the 19th century with discoveries about bone marrow's role.

The historical context reveals that early physicians like Hippocrates (460-370 BCE) recognized blood's importance but misunderstood its origins. In 1868, German pathologist Ernst Neumann first identified bone marrow as the primary site of blood cell formation in adults. Today, we know hematopoiesis is a precisely regulated process involving stem cells that can differentiate into all blood cell types. This knowledge has revolutionized treatments for blood disorders and cancers.

How It Works

Hematopoiesis involves complex cellular differentiation from hematopoietic stem cells to mature blood cells through multiple intermediate stages.

Stem Cell Differentiation: Hematopoietic stem cells in bone marrow differentiate into two main lineages: myeloid (producing red blood cells, platelets, and most white blood cells) and lymphoid (producing lymphocytes). These stem cells make up only about 0.01% of bone marrow cells but can generate approximately 10^11 blood cells daily through proliferation and differentiation.
Erythropoiesis Process: Red blood cell production, called erythropoiesis, takes about 7 days from progenitor cell to mature erythrocyte. The process is stimulated by erythropoietin hormone from kidneys, with iron, vitamin B12, and folate as essential nutrients. Each red blood cell contains about 270 million hemoglobin molecules and circulates for approximately 120 days before removal by the spleen.
Leukocyte Production: White blood cell production occurs continuously but increases during infections. Neutrophils, the most abundant white blood cells, have a production rate of about 1.6×10^9 cells/kg/day and a circulating lifespan of 5-90 hours. Lymphocytes can live for years as memory cells, while other granulocytes survive only days.
Platelet Formation: Platelets derive from megakaryocytes in bone marrow through cytoplasmic fragmentation. Each megakaryocyte can produce 1,000-3,000 platelets, with normal platelet counts ranging from 150,000 to 450,000 per microliter of blood. Platelets circulate for 7-10 days and are crucial for hemostasis and wound healing.

Key Comparisons

Feature	Embryonic/Fetal Hematopoiesis	Adult Hematopoiesis
Primary Sites	Yolk sac (3-8 weeks), liver/spleen (6 weeks-birth)	Bone marrow (flat bones: pelvis, sternum, vertebrae)
Cell Production Rate	Rapid to support growth (fetus gains ~50% blood volume in 3rd trimester)	Steady-state (~200 billion RBCs/day) with increased demand response
Extramedullary Sites	Normal in liver/spleen throughout fetal development	Only in pathological conditions (severe anemia, marrow failure)
Stem Cell Characteristics	More proliferative, greater self-renewal capacity	More quiescent, balanced differentiation
Oxygen Environment	Lower oxygen tension in fetal liver (3-5% O2)	Bone marrow hypoxia (1-6% O2) promotes erythropoiesis

Why It Matters

Clinical Significance: Understanding blood production enables diagnosis and treatment of hematologic disorders affecting approximately 1.5 million Americans with anemia alone. Bone marrow transplants, first performed successfully in 1968, now save over 20,000 lives annually worldwide by replacing defective hematopoietic systems.
Medical Applications: Hematopoietic growth factors like erythropoietin (discovered in 1977) treat anemia in chronic kidney disease and cancer patients. Colony-stimulating factors reduce infection risk during chemotherapy by boosting white blood cell production, decreasing febrile neutropenia by approximately 50%.
Research Implications: Hematopoietic stem cells are the most successfully used stem cells in medicine, with over 1 million transplants performed globally. Research continues on ex vivo blood production, with experimental systems generating transfusable red blood cells since 2011, though scaling remains challenging.

The future of hematopoiesis research focuses on improving stem cell expansion, developing artificial blood substitutes, and gene therapies for inherited blood disorders. Advances in single-cell genomics now allow tracking individual stem cell fates, revealing previously unknown heterogeneity in hematopoietic hierarchies. As regenerative medicine progresses, controlled blood production outside the body may eventually supplement traditional donation systems, particularly for rare blood types. Continued research promises not only better treatments for blood diseases but also deeper understanding of cellular differentiation principles applicable across medical science.